Case Study
Gated research platform for a peptide supplier (under NDA)
A gated customer portal and e-commerce system built for a peptide supplier — order management, customer account portal, research-focused content architecture, and payment processing for a high-risk product category.
October 2025
The challenge
The client needed a professional digital presence that converted in a market with significant content restrictions — research-use-only framing, no therapeutic health claims, but with a customer experience sophisticated enough to match the technical buyer base. Payment processing and order management presented additional complexity for a high-risk product category.
What we built
We built a Next.js storefront with gated customer portal, order management, and research-intent content architecture. The copy and content strategy was designed around research and educational intent rather than therapeutic claims — converting the target buyer (researchers, physicians, clinicians) while maintaining regulatory accuracy. Payment integration was scoped to a high-risk processor compatible with the product category.
Outcomes
The platform launched as a production-grade system with order management and customer portal operating end-to-end. Content architecture accurately represents the regulatory status of the products without making unsupported therapeutic claims. Client details are under NDA.
Tech stack
Capabilities used
Industry:
Peptide Companies →Related work
PeptideResearchAI — research intelligence platform for the peptide ecosystem
PeptideResearchAI is a Synaptis-owned research intelligence platform for the peptide ecosystem — ingesting 20+ peptide data sources, delivering AI-powered compound research tools, and serving researchers, clinicians, and peptide companies.
View case study →
AXIFI — AI-powered longevity and regenerative medicine OS
AXIFI is the flagship platform Synaptis built and operates — an AI-powered longevity and regenerative medicine OS with 50+ AI agents, 14 clinical tools, 1,000+ protocols, and a 36M+ paper research index.
View case study →Want something like this?
Tell us what you're working on — we scope before we build.